Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-07-31

AUTHORS

Mohamed E. A. Abdelrahim

ABSTRACT

Nowadays, therapeutic aerosols are commonly delivered to mechanically ventilated patients by nebulizers and pressurized metered dose inhaler attached to an adapter or a spacer. Studies with asthmatics and chronic obstructive pulmonary disease patients have confirmed that aerosol delivery during mechanical ventilation is feasible. They have also reported that the inhaled drugs administered during mechanical ventilation provide greater and faster clinical outcomes than when delivering during spontaneous unassisted breathing. Researchers studied factors that would affect aerosol delivery during mechanical ventilation. Even with the tremendous amount of publications in this area, there have still been no recommendations or guidelines released to help respiratory therapists in their decision as to when to deliver aerosol to ventilated patients. Mostly, respiratory therapists read the literature and decide accordingly what to do and which device to use for their patients. This puts the patients at risk of receiving a sub-therapeutic or toxic dose of the inhaled aerosol. Some studies raise an alarm of physician decision upon reading any released publication related to aerosol delivery in mechanical ventilation without a trusted recommendation and guidelines. This increases the need for the development of recommendations and guidelines, by a trusted board or society, for aerosol delivery to such critically ill patients. To summarize, inhaled drugs administered to critically ill patients is of benefit compared to taking the patient off the ventilator and delivering during spontaneous unassisted breathing. However, dependable guidelines are needed to optimize aerosol delivery. More... »

PAGES

125-133

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41030-018-0060-z

DOI

http://dx.doi.org/10.1007/s41030-018-0060-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105927720

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32026391


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Clinical Pharmacy Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt", 
          "id": "http://www.grid.ac/institutes/grid.440876.9", 
          "name": [
            "Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt", 
            "Clinical Pharmacy Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abdelrahim", 
        "givenName": "Mohamed E. A.", 
        "id": "sg:person.012470230550.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012470230550.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s41030-017-0033-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084041069", 
          "https://doi.org/10.1007/s41030-017-0033-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s41030-015-0010-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013773130", 
          "https://doi.org/10.1007/s41030-015-0010-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-07-31", 
    "datePublishedReg": "2018-07-31", 
    "description": "Nowadays, therapeutic aerosols are commonly delivered to mechanically ventilated patients by nebulizers and pressurized metered dose inhaler attached to an adapter or a spacer. Studies with asthmatics and chronic obstructive pulmonary disease patients have confirmed that aerosol delivery during mechanical ventilation is feasible. They have also reported that the inhaled drugs administered during mechanical ventilation provide greater and faster clinical outcomes than when delivering during spontaneous unassisted breathing. Researchers studied factors that would affect aerosol delivery during mechanical ventilation. Even with the tremendous amount of publications in this area, there have still been no recommendations or guidelines released to help respiratory therapists in their decision as to when to deliver aerosol to ventilated patients. Mostly, respiratory therapists read the literature and decide accordingly what to do and which device to use for their patients. This puts the patients at risk of receiving a sub-therapeutic or toxic dose of the inhaled aerosol. Some studies raise an alarm of physician decision upon reading any released publication related to aerosol delivery in mechanical ventilation without a trusted recommendation and guidelines. This increases the need for the development of recommendations and guidelines, by a trusted board or society, for aerosol delivery to such critically ill patients. To summarize, inhaled drugs administered to critically ill patients is of benefit compared to taking the patient off the ventilator and delivering during spontaneous unassisted breathing. However, dependable guidelines are needed to optimize aerosol delivery.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41030-018-0060-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136859", 
        "issn": [
          "2364-1754", 
          "2364-1746"
        ], 
        "name": "Pulmonary Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "spontaneous unassisted breathing", 
      "mechanical ventilation", 
      "ill patients", 
      "unassisted breathing", 
      "respiratory therapists", 
      "chronic obstructive pulmonary disease patients", 
      "obstructive pulmonary disease patients", 
      "pulmonary disease patients", 
      "clinical outcomes", 
      "disease patients", 
      "dose inhaler", 
      "aerosol delivery", 
      "toxic dose", 
      "patients", 
      "physician's decision", 
      "therapeutic aerosols", 
      "ventilation", 
      "breathing", 
      "drugs", 
      "delivery", 
      "guidelines", 
      "development of recommendations", 
      "therapists", 
      "asthmatics", 
      "inhaler", 
      "recommendations", 
      "ventilator", 
      "dose", 
      "dependable guidelines", 
      "outcomes", 
      "risk", 
      "study", 
      "nebulizer", 
      "factors", 
      "publications", 
      "benefits", 
      "need", 
      "literature", 
      "aerosols", 
      "development", 
      "decisions", 
      "delivering", 
      "area", 
      "amount", 
      "society", 
      "adapter", 
      "board", 
      "tremendous amount", 
      "issues", 
      "researchers", 
      "spacer", 
      "devices", 
      "alarms", 
      "big issue", 
      "faster clinical outcomes"
    ], 
    "name": "Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines", 
    "pagination": "125-133", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105927720"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41030-018-0060-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32026391"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41030-018-0060-z", 
      "https://app.dimensions.ai/details/publication/pub.1105927720"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_770.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41030-018-0060-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0060-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0060-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0060-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41030-018-0060-z'


 

This table displays all metadata directly associated to this object as RDF triples.

126 TRIPLES      22 PREDICATES      83 URIs      73 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41030-018-0060-z schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N29e236c8c3a6424fb1f0d3c9fcc95a3b
4 schema:citation sg:pub.10.1007/s41030-015-0010-y
5 sg:pub.10.1007/s41030-017-0033-7
6 schema:datePublished 2018-07-31
7 schema:datePublishedReg 2018-07-31
8 schema:description Nowadays, therapeutic aerosols are commonly delivered to mechanically ventilated patients by nebulizers and pressurized metered dose inhaler attached to an adapter or a spacer. Studies with asthmatics and chronic obstructive pulmonary disease patients have confirmed that aerosol delivery during mechanical ventilation is feasible. They have also reported that the inhaled drugs administered during mechanical ventilation provide greater and faster clinical outcomes than when delivering during spontaneous unassisted breathing. Researchers studied factors that would affect aerosol delivery during mechanical ventilation. Even with the tremendous amount of publications in this area, there have still been no recommendations or guidelines released to help respiratory therapists in their decision as to when to deliver aerosol to ventilated patients. Mostly, respiratory therapists read the literature and decide accordingly what to do and which device to use for their patients. This puts the patients at risk of receiving a sub-therapeutic or toxic dose of the inhaled aerosol. Some studies raise an alarm of physician decision upon reading any released publication related to aerosol delivery in mechanical ventilation without a trusted recommendation and guidelines. This increases the need for the development of recommendations and guidelines, by a trusted board or society, for aerosol delivery to such critically ill patients. To summarize, inhaled drugs administered to critically ill patients is of benefit compared to taking the patient off the ventilator and delivering during spontaneous unassisted breathing. However, dependable guidelines are needed to optimize aerosol delivery.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree true
12 schema:isPartOf Na3613c55df5f4b8ab0b59ef0898f5e56
13 Nf14ff97b936d42c882e960c00fb5444b
14 sg:journal.1136859
15 schema:keywords adapter
16 aerosol delivery
17 aerosols
18 alarms
19 amount
20 area
21 asthmatics
22 benefits
23 big issue
24 board
25 breathing
26 chronic obstructive pulmonary disease patients
27 clinical outcomes
28 decisions
29 delivering
30 delivery
31 dependable guidelines
32 development
33 development of recommendations
34 devices
35 disease patients
36 dose
37 dose inhaler
38 drugs
39 factors
40 faster clinical outcomes
41 guidelines
42 ill patients
43 inhaler
44 issues
45 literature
46 mechanical ventilation
47 nebulizer
48 need
49 obstructive pulmonary disease patients
50 outcomes
51 patients
52 physician's decision
53 publications
54 pulmonary disease patients
55 recommendations
56 researchers
57 respiratory therapists
58 risk
59 society
60 spacer
61 spontaneous unassisted breathing
62 study
63 therapeutic aerosols
64 therapists
65 toxic dose
66 tremendous amount
67 unassisted breathing
68 ventilation
69 ventilator
70 schema:name Aerosol Delivery to a Critically Ill Patient: A Big Issue Easily Solved by Developing Guidelines
71 schema:pagination 125-133
72 schema:productId N31bc73a681164f46b834febb4343bf87
73 N93eeba49497049d2881b218749cdb97e
74 Na636d361146345df8965d2efe7e5e394
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105927720
76 https://doi.org/10.1007/s41030-018-0060-z
77 schema:sdDatePublished 2021-11-01T18:32
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N807a9b3634f54d229a1020d0369f404b
80 schema:url https://doi.org/10.1007/s41030-018-0060-z
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N29e236c8c3a6424fb1f0d3c9fcc95a3b rdf:first sg:person.012470230550.42
85 rdf:rest rdf:nil
86 N31bc73a681164f46b834febb4343bf87 schema:name pubmed_id
87 schema:value 32026391
88 rdf:type schema:PropertyValue
89 N807a9b3634f54d229a1020d0369f404b schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 N93eeba49497049d2881b218749cdb97e schema:name doi
92 schema:value 10.1007/s41030-018-0060-z
93 rdf:type schema:PropertyValue
94 Na3613c55df5f4b8ab0b59ef0898f5e56 schema:volumeNumber 4
95 rdf:type schema:PublicationVolume
96 Na636d361146345df8965d2efe7e5e394 schema:name dimensions_id
97 schema:value pub.1105927720
98 rdf:type schema:PropertyValue
99 Nf14ff97b936d42c882e960c00fb5444b schema:issueNumber 2
100 rdf:type schema:PublicationIssue
101 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
102 schema:name Medical and Health Sciences
103 rdf:type schema:DefinedTerm
104 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
105 schema:name Cardiorespiratory Medicine and Haematology
106 rdf:type schema:DefinedTerm
107 sg:journal.1136859 schema:issn 2364-1746
108 2364-1754
109 schema:name Pulmonary Therapy
110 schema:publisher Springer Nature
111 rdf:type schema:Periodical
112 sg:person.012470230550.42 schema:affiliation grid-institutes:grid.440876.9
113 schema:familyName Abdelrahim
114 schema:givenName Mohamed E. A.
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012470230550.42
116 rdf:type schema:Person
117 sg:pub.10.1007/s41030-015-0010-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1013773130
118 https://doi.org/10.1007/s41030-015-0010-y
119 rdf:type schema:CreativeWork
120 sg:pub.10.1007/s41030-017-0033-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084041069
121 https://doi.org/10.1007/s41030-017-0033-7
122 rdf:type schema:CreativeWork
123 grid-institutes:grid.440876.9 schema:alternateName Clinical Pharmacy Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt
124 schema:name Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt
125 Clinical Pharmacy Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt
126 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...